CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
DTIL Precision BioSciences
- 5.640
- +0.410+7.84%
Close Apr 30 16:00 ET
- 5.640
- 0.0000.00%
Post 16:05 ET
59.50MMarket Cap5.42P/E (TTM)
5.640High5.099Low137.97KVolume5.200Open5.230Pre Close748.87KTurnover1.56%Turnover Ratio5.42P/E (Static)10.55MShares13.43652wk High1.06P/B49.77MFloat Cap3.61052wk Low--Dividend TTM8.82MShs Float710.106Historical High--Div YieldTTM10.35%Amplitude3.610Historical Low5.427Avg Price1Lot Size
Precision BioSciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 30.52%-58.45M | -121.81%-18.68M | 74.40%-5.91M | 29.64%-14.87M | 39.67%-18.98M | -83.84%-84.11M | 61.44%-8.42M | -179.12%-23.09M | 12.76%-21.13M | -8.98%-31.46M |
| Net income from continuing operations | 111.69%7.17M | -8.94%-17.75M | -103.30%-16.43M | 375.41%32.75M | 134.27%8.59M | 45.07%-61.32M | 42.82%-16.29M | 66.26%-8.08M | 61.69%-11.89M | 11.03%-25.06M |
| Operating gains losses | -851.56%-28.09M | -544.76%-6.66M | 60.92%-2.77M | -1,420.83%-6.97M | -652.01%-11.69M | -275.19%-2.95M | 158.57%1.5M | -497.87%-7.09M | -64.68%528K | 119.83%2.12M |
| Depreciation and amortization | -44.55%4.58M | -51.35%757K | -50.34%1.01M | -42.05%1.38M | -37.36%1.43M | -8.32%8.26M | -31.60%1.56M | -9.39%2.04M | 7.14%2.39M | 0.98%2.28M |
| Other non cash items | -203.40%-446K | 223.39%749K | -403.11%-1.17M | -206.67%-138K | -5.04%113K | -132.67%-147K | -220.44%-607K | 9,750.00%386K | -325.00%-45K | 270.00%119K |
| Change In working capital | -30.16%-54M | -69.51%901K | 178.08%9.9M | -165.43%-44.47M | -35.44%-20.33M | -272.07%-41.49M | 130.94%2.96M | -128.83%-12.68M | -710.15%-16.75M | -82.09%-15.01M |
| -Change in receivables | 5,046.41%8.95M | -105.83%-151K | 443.86%9.77M | 335.71%183K | -3,361.54%-848K | 21.98%-181K | 51,940.00%2.59M | -105.71%-2.84M | 100.08%42K | --26K |
| -Change in prepaid assets | -144.15%-464K | -67.92%673K | -557.59%-1.45M | 830.35%3.59M | -275.80%-3.28M | 209.25%1.05M | 134.37%2.1M | -7.06%316K | -111.09%-491K | -333.16%-872K |
| -Change in payables and accrued expense | -238.99%-2.1M | -96.41%72K | -264.71%-186K | 4.35%120K | -276.03%-2.1M | 885.62%1.51M | 489.12%2M | -113.14%-51K | 157.21%115K | -49.47%-559K |
| -Change in other current assets | -114.95%-262K | -153.99%-115K | -108.72%-51K | -102.56%-39K | 90.02%-57K | 22.43%1.75M | -96.52%213K | 550.00%585K | 130.81%1.53M | -433.92%-571K |
| -Change in other current liabilities | -95.21%-3.26M | -120.26%-461K | 367.25%1.22M | 37.90%2.09M | -21.95%-6.1M | 54.10%-1.67M | 262.38%2.28M | -195.99%-455K | -47.37%1.51M | 10.42%-5M |
| -Change in other working capital | -29.41%-56.87M | 114.18%883K | 105.83%597K | -159.06%-50.41M | 1.08%-7.95M | -260.64%-43.95M | 26.77%-6.23M | -43.89%-10.23M | -142.48%-19.46M | -183.82%-8.03M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 30.52%-58.45M | -121.81%-18.68M | 74.40%-5.91M | 29.64%-14.87M | 39.67%-18.98M | -83.84%-84.11M | 61.44%-8.42M | -179.12%-23.09M | 12.76%-21.13M | -8.98%-31.46M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -103.69%-215K | -330.95%-97K | -100.85%-64K | 97.35%-28K | 96.39%-26K | 275.63%5.83M | 106.65%42K | 793.94%7.56M | -35.56%-1.06M | 11.86%-721K |
| Net PPE purchase and sale | 89.73%-190K | -253.97%-97K | 89.90%-39K | 97.22%-28K | 95.01%-26K | 44.26%-1.85M | 109.97%63K | 64.59%-386K | -29.14%-1.01M | 36.31%-521K |
| Net intangibles purchase and sale | 92.21%-25K | --0 | 50.00%-25K | --0 | --0 | ---321K | ---21K | ---50K | ---50K | ---200K |
| Net business purchase and sale | --0 | --0 | ---- | ---- | ---- | --8M | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -103.69%-215K | -330.95%-97K | -100.85%-64K | 97.35%-28K | 96.39%-26K | 275.63%5.83M | 106.65%42K | 793.94%7.56M | -35.56%-1.06M | 11.86%-721K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 836.51%50.45M | 109.34%5.92M | 11,079.41%3.73M | -62.10%702K | 5,310.93%40.1M | -94.33%5.39M | 2.83M | 81.11%-34K | -98.01%1.85M | -67.05%741K |
| Net issuance payments of debt | ---37K | ---20K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net common stock issuance | 907.58%50.24M | 110.12%5.94M | 2,718.12%3.61M | -62.10%702K | 8,884.94%39.98M | -93.29%4.99M | --2.83M | 27.37%-138K | -97.46%1.85M | -72.65%445K |
| Proceeds from stock option exercised by employees | -37.91%249K | --0 | 31.73%137K | --0 | -62.16%112K | -51.98%401K | -80.00%1K | -38.82%104K | --0 | -52.41%296K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 836.51%50.45M | 109.34%5.92M | 11,079.41%3.73M | -62.10%702K | 5,310.93%40.1M | -94.33%5.39M | --2.83M | 81.11%-34K | -98.01%1.85M | -67.05%741K |
| Net cash flow | ||||||||||
| Beginning cash position | -38.45%116.68M | -0.74%121.33M | -10.32%123.57M | -12.88%137.77M | -38.45%116.68M | 31.96%189.58M | -42.36%122.23M | -25.17%137.79M | 36.06%158.13M | 31.96%189.58M |
| Current changes in cash | 88.74%-8.21M | -131.59%-12.86M | 85.59%-2.24M | 30.20%-14.2M | 167.07%21.09M | -258.77%-72.9M | 75.29%-5.55M | -155.75%-15.56M | -129.95%-20.34M | -14.59%-31.44M |
| End cash Position | -7.04%108.47M | -7.04%108.47M | -0.74%121.33M | -10.32%123.57M | -12.88%137.77M | -38.45%116.68M | -38.45%116.68M | -42.36%122.23M | -25.17%137.79M | 36.06%158.13M |
| Free cash flow | 32.03%-58.72M | -123.09%-18.78M | 74.60%-5.98M | 33.08%-14.9M | 40.76%-19.07M | -76.05%-86.39M | 62.55%-8.42M | -183.75%-23.53M | 10.97%-22.26M | -8.40%-32.19M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀